Tirzepatide user experiences: what users themselves report

Users’ own accounts, not research. The accounts are self-selected and prove neither that it works nor that it is safe.

This page does not list users’ doses or where they got the medicine, and no figure on it is a recommendation. The dose is for the doctor to decide: Tirzepatide dosage.

In short

Of 211 people, 165 (78%) said tirzepatide brought some benefit and 103 (49%) some harm.

Where the accounts come from and how we read them

Sources: the Reddit forums r/Zepbound (108 accounts), r/Mounjaro (91), r/WegovyWeightLoss (6), r/Ozempic (3) and r/Semaglutide (3), 16 Oct 2025 to 12 Oct 2026. The posts were retrieved from a public Reddit archive. From first-person posts about tirzepatide, 300 were picked at random, and every one was read.

Coding: for each account we recorded the route, reported benefits and harms, how strong a harm was, whether and why the person stopped, length of use and other substances used at the same time. We kept accounts that reported some effect, some harm, or no effect. Questions and plans were left out. A harm was recorded when the person reported it during use, even if the cause was uncertain. Several posts by one person count as one person. One person can mention several things, so the shares in the tables do not add up to 100.

Check: an AI model read and classified the posts following written instructions. A second, separate AI run classified a random tenth (30 posts) again without seeing the first classification. The main fields matched: 28/30 (93%). One post looked like marketing and is not in the figures.

Whose accounts these are: routes mentioned: injection 177; the others did not say. The figures describe the writers and are not a recommendation. We do not know whether the writers’ medicine came from a pharmacy or from elsewhere.

Did tirzepatide help? The overall picture

Of 211 people, 102 (48%) reported benefit only, 63 (30%) both benefit and harm, 40 (19%) harm only and 6 (3%) neither.

Stopping. 14 people (7%) said they stopped or paused: 8 because of harms and 6 because they noticed no effect or for another reason.

Share = people / 211.
Overall picture: benefit, harm or neitherPeopleShare
Benefit only10248%
Both benefit and harm6330%
Harm only4019%
Neither benefit nor harm63%

Most common reported benefits

Of 211 people. 165 (78%) mentioned some benefit; the table lists every benefit reported.

ReportedPeopleShare
Weight loss13765%
Less appetite and food noise4923%
Better blood sugar or HbA1c157%
Better mood105%
More energy42%
Better sleep or sleep apnoea31%
Less joint pain21%
Less urge to drink10%
Other benefit126%

Share = people / 211.

Most common reported harms

Of 211 people. 103 (49%) mentioned some harm; 8 said explicitly they had none.

ReportedPeopleShare
Nausea3718%
Burping147%
Food aversion or eating too little115%
Constipation115%
Diarrhoea115%
Stomach pain or bloating105%
Fatigue105%
Heartburn or reflux94%
Insomnia or sleep problems94%
Vomiting94%
Mood or anxiety63%
Gallbladder52%
Skin pain, tingling or burning52%
Hair loss42%
Headache42%
Injection site reaction31%
Loose skin or facial change21%
Allergic reaction, hives or rash10%
Dizziness10%
Raised heart rate or palpitations10%
Low blood sugar10%
Muscle loss or weakness10%
Pancreatitis10%
Other, rarer harm168%
Harms mentioned but not named63%

Share = people / 211.

How severe were the harms?

Of the 101 people who described how strong a harm was, 35 (35%) described it as mild, 55 (54%) as clearly bothersome and 11 (11%) as severe. The strength is the writer's own description, not a doctor's assessment.

Share = people / 101.
Strength of the harm as the writer described itPeopleShare
Mild: minor and manageable3535%
Clearly bothersome: several days, sleep or work affected5554%
Severe: emergency visit, hospital or unable to function1111%

Harms known from research and regulators: What are the side effects of tirzepatide?

How long did people use tirzepatide?

165 of 211 people (78%) said how long they had been using it at the time of writing. Where one person wrote several posts, the longest stated time counts.

Share = people / 165.
Stated length of usePeopleShare
Under a week1610%
1-4 weeks2515%
1-3 months4427%
Over 3 months8048%

Many people post partway through, often in the first days or as soon as harms start, so short times are over-represented. The numbers describe the writers; they do not say how long it should be used.

Other substances at the same time

14 of 211 people (7%) mentioned using other medicines or products at the same time. We do not name them on this page.

A prescription medicine: what this page does not tell

Tirzepatide is a prescription medicine; whether to use it and at what dose is for the doctor to decide. We did not record doses, dose changes, where the medicine came from or how much weight was lost, and we do not name the other medicines people used at the same time. Side effects seen in trials: What are the side effects of tirzepatide?

The weight-loss drug side-effects guide has its own section on the side effects users report: what users themselves report about side effects. Its side-effect shares are higher than on this page because its posts were chosen for side-effect wording, while this page's posts are drawn from all posts about the medicine.

About dosing

We do not repeat the amounts or ways of use people mention, and we give no dosing or how-to instructions. The dose is for the doctor to decide. Approved doses and trial doses, with sources: Tirzepatide dosage in studies and in the product information. Legal status: Is tirzepatide legal in Finland?

What can be concluded?

Weight loss and less appetite were the most common reported benefits and nausea the most common harm. The accounts do not tell how much weight was lost, and they do not replace a doctor's assessment.

The accounts prove neither that it works nor that it is safe. The writers are self-selected, people tend to post when something goes wrong, and the accounts cannot separate the effect of the medicine from other causes. The research and its evidence levels: Tirzepatide: what the research shows.

Quotes

Short excerpts in the writers’ own words. Writers’ names and links are not shown. We picked quotes from every group: benefit, both benefit and harm, no effect, harms and people who stopped.

Other summaries made with the same method: BPC-157 user experiences, Retatrutide user experiences, Cagrilintide user experiences, Semaglutide user experiences, Liraglutide user experiences, NAD+ user experiences, MOTS-c user experiences and user experiences with collagen and skin peptides.

Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.